Dr. Kc Bens, MD
What this data tells you about Dr. Bens
Dr. Kc Bens is an urology physician in Dallas, TX, with 10 years of NPI registration. Based on federal Medicare data, Dr. Bens performed 1,663 Medicare services across 852 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bens received a total of $6,291 from 42 pharmaceutical and/or device companies across 163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bens is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test | 378 | $34 | $70 |
| Automated urinalysis | 208 | $2 | $5 |
| Office visit, established patient (30-39 min) | 118 | $98 | $259 |
| Bladder ultrasound after voiding | 117 | $8 | $22 |
| Yeast/candida DNA test | 87 | $34 | $70 |
| Urine culture, bacterial colony count | 86 | $8 | $16 |
| New patient office visit (45-59 min) | 75 | $115 | $336 |
| Office visit, established patient (20-29 min) | 64 | $63 | $183 |
| Urine culture, bacterial identification | 55 | $8 | $16 |
| Ceftriaxone antibiotic injection | 52 | $0 | $1 |
| Diagnostic exam of bladder and urethra using an endoscope | 43 | $191 | $495 |
| Blood draw (venipuncture) | 42 | $8 | $16 |
| Detection test by nucleic acid for mycobacteria tuberculosis (tb bacteria), amplified probe technique | 30 | $41 | $83 |
| Detection of mycoplasma genitalium by dna or rna probe | 30 | $34 | $70 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 30 | $34 | $70 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 30 | $34 | $70 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 30 | $34 | $70 |
| Bacterial culture, aerobic | 27 | $8 | $16 |
| Antibiotic sensitivity test | 27 | $8 | $17 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 23 | $34 | $70 |
| PSA test (prostate cancer screening) | 19 | $18 | $37 |
| Detection test for gardnerella vaginalis (bacteria), amplified probe technique | 15 | $34 | $70 |
| Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | 13 | $34 | $70 |
| Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique | 13 | $34 | $70 |
| Detection test by nucleic acid for herpes virus-6, amplified probe technique | 13 | $34 | $70 |
| Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | 13 | $34 | $70 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 13 | $34 | $70 |
| Initial hospital admission, high complexity | 12 | $136 | $353 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bens is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bens experienced with infectious disease dna/rna test?
Does Dr. Bens receive payments from pharmaceutical companies?
How do Dr. Bens's costs compare to other urology physicians in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology